Hanna M. Romanska-Knight

Lodz, LD 92213, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs.

FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs.

Journal: Cellular & molecular biology letters

Published: November 29, 2023

FGFR4-driven plasticity in breast cancer progression and resistance to therapy.

FGFR4-driven plasticity in breast cancer progression and resistance to therapy.

Journal: British journal of cancer

Published: November 20, 2023

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli.

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli.

Journal: Neoplasia (New York, N.Y.)

Published: July 07, 2020

FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.

FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 20, 2019

Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution?

Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution?

Journal: Cancers

Published: December 14, 2018

Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells.

Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: November 11, 2018

CD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathways.

CD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathways.

Journal: Journal of cell science

Published: May 22, 2018

MicroRNAs in regulation of triple-negative breast cancer progression.

MicroRNAs in regulation of triple-negative breast cancer progression.

Journal: Journal of cancer research and clinical oncology

Published: May 15, 2018

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.

Journal: Neoplasia (New York, N.Y.)

Published: April 24, 2017

Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.

Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: April 02, 2016

Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.

Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.

Journal: Biochimica et biophysica acta

Published: February 07, 2014

Loss of CD151/Tspan24 from the complex with integrin α3β1 in invasive front of the tumour is a negative predictor of disease-free survival in oral squamous cell carcinoma.

Loss of CD151/Tspan24 from the complex with integrin α3β1 in invasive front of the tumour is a negative predictor of disease-free survival in oral squamous cell carcinoma.

Journal: Oral oncology

Published: April 23, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026